Senseonics (NYSE: SENS) has launched its first clinical study of a transmitter-free version of its Eversense 365 continuous glucose monitor. The first-in-human trial of its Freedom system will evaluate a one-year, under-the-skin sensor that links directly with the user’s smartphone, doing away with the need for additional on-body hardware and making a CGM as discreet […]
Enable Injections, Sanofi obtain approval for on-body myeloma therapy in Japan
After obtaining U.S. and European approvals this summer, Enable Injections has claimed its first regulatory green light in Japan for its enFuse wearable drug delivery technology. The country’s Ministry of Health, Labour and Welfare approved Sanofi’s push-button CirCLIQ Injector for administering a subcutaneous formulation of Sarclisa (isatuximab-irfc), a monoclonal antibody for multiple myeloma used in […]
Abbott sets Libre Duo glucose-ketone sensor US launch for December
After claiming an FDA de novo nod in August, Abbott (NYSE: ABT) said it plans to launch its Libre Duo dual-analyte sensor in the U.S. this December. The roll out of the new continuous glucose monitor, which also tracks ketone levels to safeguard against diabetic ketoacidosis, will come after its international debut set for this […]
Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
Sequel Med Tech‘s twiist automated insulin delivery system obtained an FDA clearance opening up its use to adults with type 2 diabetes. Launched earlier this year for people with type 1 diabetes, the company estimates the agency’s green light adds about 5.5 million people in the U.S. who manage their condition with insulin. Available through […]
MiniMed completes split from Medtronic
MiniMed (Nasdaq: MMED) is celebrating its first day as an independent diabetes tech company, with the full completion of its spinoff from the Medtronic mothership. This week Medtronic reported the final results of its exchange offer for MiniMed stock, where it divested all of its remaining equity stake in the company through the swapping of […]
Insulet’s Omnipod Discover data platform begins full US rollout
Insulet’s (NASDAQ: PODD) web-based diabetes data platform is making its way to the U.S., designed to offer Omnipod users a view into their glucose and insulin trends while providing clinicians a way to deliver personalized recommendations. Dubbed Omnipod Discover, the system made its debut in multiple international markets earlier this year. Ahead of its full […]
BD’s IV catheters plant in Utah marks 70 years
BD (NYSE:BDX) is celebrating the 70th birthday of its major manufacturing facility in Utah, which the company said produces billions of molded components each year. Located in the town of Sandy just south of Salt Lake City, the site was founded in 1956 under Deseret Pharmaceuticals. BD acquired the plant in 1986, and today it’s […]
Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
Novo (NYSE: NVO) has tapped the Swedish drug-delivery developer Nanexa to develop long-acting injectable platforms for its peptide meds, with a global licensing deal worth €1.165 billion, or about $1.32 billion U.S. The deal will support up to five R&D programs targeting monthly and quarterly injections, as the drugmaker looks to extend the reach of […]
Abbott partners with Berry Street to add nutrition coaching to Lingo
Abbott (NYSE: ABT) is teaming up with Berry Street to offer dietitian support programs to Lingo users. Wearers of the over-the-counter continuous glucose monitor can now sign up for personalized nutrition coaching linked to their data trends, and schedule virtual one-on-one appointments with registered and insurance-covered dietitians. At the same time, Berry Street users will […]
Dexcom CFO to expand into COO role
Dexcom‘s (Nasdaq:DXCM) C-suite is seeing another of its members take on multiple roles. Its chief financial officer will now also serve as chief operating officer. Jereme Sylvain joined the diabetes tech company in 2018, and has been its CFO and executive VP since 2021. His new COO hat will add oversight of Dexcom’s global operations […]
